Safety and Efficacy of Topical NVC-422 Gel in Impetigo
This study has been completed.
Sponsor:
NovaBay Pharmaceuticals, Inc.
Collaborators:
Novum Pharmaceutical Research Services
International Dermatology Research
Information provided by:
NovaBay Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01367314
First received: June 3, 2011
Last updated: June 6, 2011
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2010 |
| Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |